Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06305793
What this trial is testing

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Who this might be right for
Long COVIDLong Coronavirus Disease 2019 (Covid19)Long Covid-19
Kanecia Obie Zimmerman 200
Not applicableUnknownNCT04452942
What this trial is testing

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
EicOsis Human Health Inc. 30
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Testing effectiveness (Phase 2)Study completedNCT04402866
What this trial is testing

TD-0903 for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19
Theravance Biopharma 235
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Early research (Phase 1)Study completedNCT04429529
What this trial is testing

Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 32
Not applicableStudy completedNCT05410808
What this trial is testing

Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

Who this might be right for
FibromyalgiaCoronavirus Disease 2019 Pandemic
Ege University 78
Early research (Phase 1)WithdrawnNCT04464460
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Who this might be right for
Coronavirus Disease
Takeda
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Not applicableEnded earlyNCT06703190
What this trial is testing

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Who this might be right for
COVID-19
Pfizer 1
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT05091411
What this trial is testing

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,680
Testing effectiveness (Phase 2)Study completedNCT04478071
What this trial is testing

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirus Infection
The University of Texas Health Science Center, Houston 448
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Not applicableStudy completedNCT04430322
What this trial is testing

Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

Who this might be right for
COVID
Centre Hospitalier Régional Metz-Thionville 1,045
Not applicableUnknownNCT06142201
What this trial is testing

A Real-World Study of JT001 for COVID-19

Who this might be right for
COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 7,656
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation